peoplePerson
Louis M. Staudt
Louis Staudt defined the molecular subtypes of large B-cell lymphoma that guide targeted therapy.
Discovered the germinal-centre and activated B-cell subtypes of DLBCL and the chronic active BCR signalling that made BTK inhibitors work in lymphoma; directs NCI's cancer genomics centre.
Role
Director, Center for Cancer Genomics; Chief, Lymphoid Malignancies Branch
Institution
Specialisms
Lymphoma genomicsMolecular subtypes of DLBCLBTK signalling
Profiles
| Title | Journal | Year |
|---|---|---|
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Nature | 2000 |
| Genetics and pathogenesis of diffuse large B-cell lymphoma | New England Journal of Medicine | 2018 |